Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to assess the efficacy of a 2-session intervention to reduce nightmares among Veterans admitted VA mental health residential rehabilitation treatment programs.


Clinical Trial Description

Sleep disturbances and suicide are highly prevalent among Veterans and recent research also suggests high comorbid rates of sleep and suicide in Veterans discharged from VA mental health residential rehabilitation treatment programs (MHRRTP; domiciliaries). Nightmares are a frequent concern identified by MHRRTP patients and are a modifiable risk factor for suicide risk. Little is known, however, about the treatment of nightmares and subsequent impact in this setting. The primary aims of the present project are to investigate the efficacy and acceptability of delivering a 2-session intervention to reduce nightmares among Veterans admitted to a MHRRTP. This study will examine this intervention's impact on reducing nightmare distress and nightmare frequency, as well as assess treatment acceptability. Changes in suicide risk following intervention will also be explored. This research will be conducted within the Canandaigua and Bath VA domiciliary programs which currently accommodate ~150-175 Veterans. The study will be a randomized control trial with a hybrid design that uses stratification based on prescription use and randomly assigns individuals (N = 48) to either the treatment group or treatment as usual group (TAU). Veterans referred for the protocol will be screened for eligibility and then if appropriate, scheduled for a baseline evaluation, randomized to either the treatment group or TAU group, seen for two intervention sessions one week apart, and then be followed up with 4- and 8-weeks post initial treatment via telephone. This research has potential to highlight valuable targets for cross-cutting treatment in a rehabilitation setting that can be delivered in civilian and Veteran samples. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04341987
Study type Interventional
Source Canandaigua VA Medical Center
Contact
Status Withdrawn
Phase N/A
Start date January 2021
Completion date June 2021

See also
  Status Clinical Trial Phase
Completed NCT05588739 - Cognitive-Behavioral Therapy for Children With Nightmares as a Mediator of Suicide Risk (COMAA) N/A
Completed NCT03532269 - Validation of the Sleep Assessment Algorithm in the Medical Application Nightly N/A
Completed NCT04776304 - Art Therapy qEEG Study for Service Members With a Traumatic Brain Injury and Posttraumatic Stress Symptoms N/A
Not yet recruiting NCT06419959 - NightWare and Cardiovascular Health in Veterans With PTSD N/A
Recruiting NCT04198142 - Psychiatric Inpatient Nightmare Treatment N/A
Completed NCT03934658 - Remote Study of NightWare for PTSD With Nightmares N/A
Not yet recruiting NCT06410118 - The DreamChanger Intervention in Combination With Imagery Rehearsal Therapy for Children's Nightmares N/A
Completed NCT04047277 - Cognitive Behavioral Therapy for Nightmares in Children N/A
Recruiting NCT05365607 - NightWare and Cardiovascular Health in Adults With PTSD N/A
Enrolling by invitation NCT04040387 - Traumatic Nightmares Treated by NightWare (To Arouse Not Awaken) N/A
Not yet recruiting NCT06383806 - Decreasing Nightmares in Adults With Narcolepsy N/A
Not yet recruiting NCT06441864 - Behavioral Treatment for Nightmares in REM Sleep Behavior Disorder N/A
Recruiting NCT04529070 - Nightmare Rescripting and Rehearsal N/A
Completed NCT03795987 - Traumatic Nightmares Treated by NightWare (To Arouse Not Awaken) N/A
Recruiting NCT05414708 - Art Therapy and Emotional Well Being in Military Populations With Posttraumatic Stress Symptoms N/A
Enrolling by invitation NCT03828656 - NightWare Open Enrollment Study N/A
Recruiting NCT05950035 - An Efficient Treatment for Posttraumatic Injury for Firefighters N/A
Recruiting NCT06033781 - Cognitive-Behavioral Therapy for Children With Nightmares N/A
Completed NCT03831412 - Cognitive Behavioral Therapy for Insomnia vs. Exposure, Relaxation, and Rescripting Therapy N/A